Assertio Therapeutics Inc (ASRT) earnings · rev $118.7M
These earnings events as JSON? API free 100/dayAssertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
This ASRT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ASRT revenue for 2025-12-31 was $118.7M. Net income was -$30.4M. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. ASRT currently screens at market cap $151.5M.
When the next ASRT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 5.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ASRT research stays on the stock page; the tape stays on the quote page.
ASRT earnings FAQ
What are ASRT's latest revenue and net income?
Latest cached Assertio Therapeutics Inc (ASRT) revenue for Dec 31, 2025 was $118.7M. Net income was -$30.4M. Statements: https://lician.com/financials/asrt
What is ASRT's latest diluted EPS?
Latest cached Assertio Therapeutics Inc (ASRT) diluted EPS for Dec 31, 2025 was -$4.74.
What period does the latest ASRT earnings print cover?
The latest cached Assertio Therapeutics Inc (ASRT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ASRT revenue change from the prior cached period?
Cached Assertio Therapeutics Inc (ASRT) revenue was down 5.0% from $125.0M (Dec 31, 2024) to $118.7M (Dec 31, 2025). Statements: https://lician.com/financials/asrt
Where are ASRT earnings listed?
Cached earnings facts for Assertio Therapeutics Inc (ASRT) are listed at https://lician.com/earnings/asrt. Statements: https://lician.com/financials/asrt
Not investment advice.